Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 147

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 147
---
 holder and bears simple interest at a rate of 15% per annum.

$15,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on May 3. 2025 and bears simple interest at a rate of 10% per annum.

$25,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on June 5. 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc. and the Company are under common control.

(b) NON RELATED PARTY

Notes payable consisted of the following:

|                                           |     | As of September 30, |    2024 |   |     |   |    2023 |
|:------------------------------------------|:----|:--------------------|--------:|:--|:----|:--|--------:|
| Bostonia Partners, Inc.                   |     | $                   |  48,500 |   |     | $ |  95,000 |
| Coventry Enterprises LLC (Long Term)      |     |                     |       - |   |     |   | 149,613 |
| Coventry Enterprises LLC (Short Term)     |     |                     | 250,000 |   |     |   |       - |
| Less: Amortizatio of Notes                |     |                     | (46,389 | ) |     |   |       - |
| Total notes payable to un-related parties |     | $                   | 252,111 |   |     | $ | 244,613 |
| Total Notes Payable Short Term            |     |                     | 293,819 |   |     |   |  95,710 |
| Total Notes Payable Long Term             |     |                     |       - |   |     |   | 149,613 |

$48,500 lent to the Company by Bostonia Partners, Inc is due and payable on March 10, 2024 and bears simple interest at a rate of 10% per annum.

Effective September 4, 2024 the Company entered into a securities purchase agreement (the “Purchase Agreement”) with Coventry Enterprises, LLC (“Coventry”), pursuant to which Coventry Enterprises purchased a 10% unsecured promissory Note (the “Note”) from the Company in the principal amount of $250,000 for consideration of $200,000.

$152,000 of the proceeds received has been